Researchers from Moorfields Eye Hospital and University College London (UCL) have identified markers in the blood that may predict which Glaucoma patients are likely to continue losing vision despite treatment that aims to lower the pressure that causes their sight loss. Professor Ted Garway-Heath tells In Touch more about their clinical trial.

On In Touch, we've always tried to be careful not to raise false hopes about new eye treatments, but occasionally its too irresistible to not take a peek into the future and look at how modern technology might help us. Developments such as Artificial Intelligence are happening so rapidly, even in the world of eye care. Pete Thomas is the Executive Director of Digital Development at Moorfield's Eye Hospital and he tells In Touch about the application of AI which is already having an effect on the rate of diagnosis of eye conditions, and therefore the speed with which they can be treated.

Presenter: Peter White